Synairgen Future Growth
Future criteria checks 0/6
Synairgen is forecast to grow earnings at 50.2% per annum. EPS is expected to grow by 50.2% per annum.
Key information
50.2%
Earnings growth rate
50.2%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 03 Sep 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | N/A | -7 | -7 | -7 | N/A |
| 3/31/2024 | N/A | -8 | -7 | -7 | N/A |
| 12/31/2023 | N/A | -8 | -8 | -8 | N/A |
| 9/30/2023 | N/A | -9 | -6 | -6 | N/A |
| 6/30/2023 | N/A | -10 | -4 | -4 | N/A |
| 3/31/2023 | N/A | -14 | -9 | -9 | N/A |
| 12/31/2022 | N/A | -18 | -14 | -14 | N/A |
| 9/30/2022 | N/A | -23 | -21 | -21 | N/A |
| 6/30/2022 | N/A | -28 | -28 | -28 | N/A |
| 3/31/2022 | N/A | -38 | -35 | -35 | N/A |
| 12/31/2021 | N/A | -49 | -41 | -41 | N/A |
| 9/30/2021 | N/A | -46 | -44 | -44 | N/A |
| 6/30/2021 | N/A | -43 | -48 | -48 | N/A |
| 3/31/2021 | N/A | -28 | -36 | -36 | N/A |
| 12/31/2020 | N/A | -14 | -24 | -24 | N/A |
| 9/30/2020 | N/A | -10 | -15 | -15 | N/A |
| 6/30/2020 | N/A | -6 | -6 | -6 | N/A |
| 3/31/2020 | N/A | -5 | -4 | -4 | N/A |
| 12/31/2019 | N/A | -4 | -3 | -3 | N/A |
| 9/30/2019 | 0 | -4 | -4 | -4 | N/A |
| 6/30/2019 | 0 | -4 | -4 | -4 | N/A |
| 3/31/2019 | 0 | -3 | -4 | -4 | N/A |
| 12/31/2018 | 0 | -3 | -4 | -4 | N/A |
| 9/30/2018 | 3 | -1 | -1 | -1 | N/A |
| 6/30/2018 | 5 | 2 | 2 | 2 | N/A |
| 3/31/2018 | 5 | 2 | N/A | 2 | N/A |
| 12/31/2017 | 5 | 2 | N/A | 2 | N/A |
| 9/30/2017 | 3 | 0 | N/A | -1 | N/A |
| 6/30/2017 | 0 | -3 | N/A | -3 | N/A |
| 3/31/2017 | 0 | -3 | N/A | -3 | N/A |
| 12/31/2016 | N/A | -3 | N/A | -3 | N/A |
| 9/30/2016 | N/A | -3 | N/A | -3 | N/A |
| 6/30/2016 | N/A | -3 | N/A | -2 | N/A |
| 3/31/2016 | 0 | -2 | N/A | -2 | N/A |
| 12/31/2015 | 0 | -2 | N/A | -2 | N/A |
| 9/30/2015 | 0 | -2 | N/A | -2 | N/A |
| 6/30/2015 | 0 | -2 | N/A | -2 | N/A |
| 3/31/2015 | 2 | 0 | N/A | 0 | N/A |
| 12/31/2014 | 4 | 1 | N/A | 2 | N/A |
| 9/30/2014 | 4 | 1 | N/A | 2 | N/A |
| 6/30/2014 | 4 | 1 | N/A | 3 | N/A |
| 3/31/2014 | 2 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMY is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OMY is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OMY is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if OMY's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if OMY's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OMY's Return on Equity is forecast to be high in 3 years time